查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1604692

人造器官和仿生市场：按产品和技术分類的全球预测 - 2025-2030

Artificial Organ & Bionics Market by Product (Artificial Bionics, Artificial Organ), Technology (Electronic, Mechanical) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，人造器官和仿生市场价值为233.4亿美元，预计到2024年将达到254.5亿美元，复合年增长率为9.10%，到2030年将达到429.7亿美元。

人造器官和仿生市场涉及生物相容性设备的开发，这些设备可增强或取代故障的器官和组织的功能。它是生物技术和生物工程的结合所定义的，包括人工肾臟、人工心臟、人工肺部和人工耳等。由于器官衰竭、慢性疾病增加和捐赠器官短缺，这一阶段是必要的。应用涵盖许多医疗领域，特别是在心臟和糖尿病管理（矫正器具仿生胰腺）、运动性能增强（义肢）和感觉恢復（人工电子耳）方面。最终用户主要包括医院、研究机构以及需要復健和改善生活品质的患者。

主要市场统计
基准年[2023] 233.4亿美元
预计年份 [2024] 254.5亿美元
预测年份 [2030] 429.7亿美元
复合年增长率（%） 9.10%

市场成长的关键驱动力是 3D 列印和干细胞技术等技术进步，这些技术正在彻底改变设备製造和个人化医疗。有利的监管措施和不断增长的医疗保健支出将进一步推动市场扩张。在人口老化和器官衰竭盛行率不断增加的市场中，机会无所不在。新兴地区、技术先进的产品供应以及创新解决方案联盟是潜在的成长要素。公司应透过投资研发、形成策略联盟并强调个人化医疗以渗透市场来抓住这些机会。

然而，市场面临着高昂的开发和实施成本、严格的监管合规性以及有关长期整合和功能的道德问题等限制。此外，技术的复杂性和所需的多学科专业知识为快速市场引入带来了挑战。

创新应着重于提高设备的生物相容性和使用寿命、降低製造成本，并利用人工智慧在患者特定解决方案中进行预测分析。探索侵入性较小的安装方法并整合物联网进行监控也可能会增加竞争。市场充满活力且快速成长，但迫切需要平衡成本、可近性和创新性。成功需要一种策略方法，重点是克服现有的限制，同时利用新的机会。

市场动态：快速发展的人造器官和仿生市场的关键市场洞察

人造器官和仿生市场正因供需的动态互动而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 慢性疾病导致的器官衰竭增加
    • 导致截肢的案例增加
    • 实现医疗基础设施现代化并增加医疗支出
  • 市场限制因素
    • 人工移植手术的高成本
  • 市场机会
    • 人工器官移植技术的进展
    • 开发新的和改进的人造器官
  • 市场问题
    • 是否有严格的法律规范？

波特的五力：驾驭人造器官与仿生市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解外部对人造器官和仿生市场的影响

外部宏观环境因素在塑造人造器官和仿生市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解人造器官和仿生市场的竞争状况

人工器官和仿生学市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵：人造器官与仿生市场供应商绩效评估

FPNV 定位矩阵是评估人工器官和仿生市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：在人造器官和仿生市场上开闢成功之路

人造器官和仿生市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病导致器官衰竭的发生率增加
      • 导致截肢的交通事故增加
      • 医疗基础设施现代化和医疗费用上涨
    • 抑制因素
      • 人工移植手术的高成本
    • 机会
      • 人工器官移植手术的进展
      • 开发新的和改进的人造器官
    • 任务
      • 严格的法规结构的可用性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章人造器官与仿生市场：副产品

  • 介绍
  • 人工仿生学
    • 仿生肢体
    • 脑仿生学
    • 人工电子耳
    • 外骨骼
    • 视觉仿生学
  • 人造器官
    • 心
    • 肾
    • 肝
    • 肺
    • 胰臟

第七章人造器官与仿生市场：依技术分类

  • 介绍
  • 电子的
  • 机器

第八章 北美、南美人工器官及仿生市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太人工器官及仿生市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲的人造器官和仿生市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Alt-Bionics, LLC
  • Axiles Bionics
  • Baxter International Inc.
  • Berlin Heart GmbH
  • Beta Bionics, Inc.
  • Bionic India
  • Boston Scientific Corporation
  • Carmat SA
  • COVVI Ltd.
  • Ekso Bionics Holdings, Inc.
  • German Bionic Systems GmbH
  • iWALKFree, Inc.
  • Jarvik Heart, Inc.
  • Medtronic Plc
  • Nipro Corporation
  • Open Bionics Ltd.
  • Pixium Vision SA
  • ReWalk Robotics Ltd.
  • Sonova AG
  • SynCardia Systems, LLC
  • Vivani Medical, Inc.
  • Zimmer Biomet Holdings, Inc.
  • Ossur hf.
Product Code: MRR-A339DAEFA09B

The Artificial Organ & Bionics Market was valued at USD 23.34 billion in 2023, expected to reach USD 25.45 billion in 2024, and is projected to grow at a CAGR of 9.10%, to USD 42.97 billion by 2030.

The artificial organ and bionics market involves the development of biocompatible devices that enhance or substitute the function of impaired organs or tissues. Defined by its integration of biotechnology and bioengineering, the scope encompasses artificial kidneys, hearts, lungs, ears, and more. This field is necessitated by the rising prevalence of organ failures, chronic diseases, and the shortage of donor organs. Applications span numerous medical fields, prominently in cardiac and diabetes management (e.g., bionic pancreas), mobility enhancement (prosthetics), and sensory restoration (cochlear implants). End-users predominantly include hospitals, research institutions, and patients requiring rehabilitation or quality of life improvements.

KEY MARKET STATISTICS
Base Year [2023] USD 23.34 billion
Estimated Year [2024] USD 25.45 billion
Forecast Year [2030] USD 42.97 billion
CAGR (%) 9.10%

Market growth is primarily driven by technological advancements, such as 3D printing and stem cell technology, which are revolutionizing device manufacturing and personalized medicine. Favorable regulatory policies and increased healthcare expenditure further catalyze market expansion. Opportunities abound in markets with aging populations and increasing incidence of organ failure. Emerging regions, technologically advanced product offerings, and collaborations for innovative solutions are potential levers for growth. Businesses should pivot towards these opportunities by investing in R&D, forming strategic alliances, and emphasizing personalized medicine for market penetration.

However, the market faces constraints, including high costs of development and implementation, stringent regulatory compliance, and ethical concerns regarding long-term integration and functionality. Additionally, technological complexity and required multidisciplinary expertise pose challenges for swift market adoption.

To innovate, focus should be on enhancing biocompatibility and longevity of devices, reducing manufacturing costs, and leveraging AI for predictive analytics in patient-specific solutions. Exploring minimally invasive installation methods and integrating IoT for monitoring could also provide a competitive edge. The market is dynamic and burgeoning, yet intensely requires balancing cost, accessibility, and technological innovation. A strategic approach focusing on overcoming existing limitations while capitalizing on new opportunities will be critical for success.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Organ & Bionics Market

The Artificial Organ & Bionics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of organ failure due to chronic diseases
    • Increasing cases of road accidents leading to amputations
    • Modernization of healthcare infrastructure and rise in healthcare spending
  • Market Restraints
    • High costs associated with artificial implantation procedures
  • Market Opportunities
    • Advancement in the implantation of artificial organ procedures
    • Development of new and improved artificial organs
  • Market Challenges
    • Availability of stringent regulatory frameworks

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Organ & Bionics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Organ & Bionics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Organ & Bionics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Organ & Bionics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Organ & Bionics Market

A detailed market share analysis in the Artificial Organ & Bionics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Organ & Bionics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Organ & Bionics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Organ & Bionics Market

A strategic analysis of the Artificial Organ & Bionics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Organ & Bionics Market, highlighting leading vendors and their innovative profiles. These include Alt-Bionics, LLC, Axiles Bionics, Baxter International Inc., Berlin Heart GmbH, Beta Bionics, Inc., Bionic India, Boston Scientific Corporation, Carmat SA, COVVI Ltd., Ekso Bionics Holdings, Inc., German Bionic Systems GmbH, iWALKFree, Inc., Jarvik Heart, Inc., Medtronic Plc, Nipro Corporation, Open Bionics Ltd., Pixium Vision SA, ReWalk Robotics Ltd., Sonova AG, SynCardia Systems, LLC, Vivani Medical, Inc., Zimmer Biomet Holdings, Inc., and Ossur hf..

Market Segmentation & Coverage

This research report categorizes the Artificial Organ & Bionics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Artificial Bionics and Artificial Organ. The Artificial Bionics is further studied across Bionic Limbs, Brain Bionics, Cochlear Implants, Exoskeleton, and Vision Bionics. The Artificial Organ is further studied across Heart, Kidney, Liver, Lungs, and Pancreas.
  • Based on Technology, market is studied across Electronic and Mechanical.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of organ failure due to chronic diseases
      • 5.1.1.2. Increasing cases of road accidents leading to amputations
      • 5.1.1.3. Modernization of healthcare infrastructure and rise in healthcare spending
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with artificial implantation procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancement in the implantation of artificial organ procedures
      • 5.1.3.2. Development of new and improved artificial organs
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of stringent regulatory frameworks
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Artificial Organ & Bionics Market, by Product

  • 6.1. Introduction
  • 6.2. Artificial Bionics
    • 6.2.1. Bionic Limbs
    • 6.2.2. Brain Bionics
    • 6.2.3. Cochlear Implants
    • 6.2.4. Exoskeleton
    • 6.2.5. Vision Bionics
  • 6.3. Artificial Organ
    • 6.3.1. Heart
    • 6.3.2. Kidney
    • 6.3.3. Liver
    • 6.3.4. Lungs
    • 6.3.5. Pancreas

7. Artificial Organ & Bionics Market, by Technology

  • 7.1. Introduction
  • 7.2. Electronic
  • 7.3. Mechanical

8. Americas Artificial Organ & Bionics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Artificial Organ & Bionics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Artificial Organ & Bionics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alt-Bionics, LLC
  • 2. Axiles Bionics
  • 3. Baxter International Inc.
  • 4. Berlin Heart GmbH
  • 5. Beta Bionics, Inc.
  • 6. Bionic India
  • 7. Boston Scientific Corporation
  • 8. Carmat SA
  • 9. COVVI Ltd.
  • 10. Ekso Bionics Holdings, Inc.
  • 11. German Bionic Systems GmbH
  • 12. iWALKFree, Inc.
  • 13. Jarvik Heart, Inc.
  • 14. Medtronic Plc
  • 15. Nipro Corporation
  • 16. Open Bionics Ltd.
  • 17. Pixium Vision SA
  • 18. ReWalk Robotics Ltd.
  • 19. Sonova AG
  • 20. SynCardia Systems, LLC
  • 21. Vivani Medical, Inc.
  • 22. Zimmer Biomet Holdings, Inc.
  • 23. Ossur hf.

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL ORGAN & BIONICS MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ARTIFICIAL ORGAN & BIONICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ARTIFICIAL ORGAN & BIONICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL ORGAN & BIONICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ARTIFICIAL ORGAN & BIONICS MARKET DYNAMICS
  • TABLE 7. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMBS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BRAIN BIONICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COCHLEAR IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY EXOSKELETON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY VISION BIONICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY KIDNEY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY LIVER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY LUNGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PANCREAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ELECTRONIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. ARTIFICIAL ORGAN & BIONICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. ARTIFICIAL ORGAN & BIONICS MARKET, FPNV POSITIONING MATRIX, 2023